{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:34:18Z","timestamp":1793838858143,"version":"4.6.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JASN"],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:sec>\n                    <jats:title>Significance Statement<\/jats:title>\n                    <jats:p>Biomarkers for noninvasive diagnosis of subclinical acute rejection are needed to enable risk-stratification and tailoring of immunosuppression for kidney transplant recipients. Using RNA sequencing analyses of whole blood collected from a cohort of transplant recipients at the time of surveillance biopsy, the authors identified a transcriptional signature on the basis of a set of 17 genes that accurately detects ongoing subclinical rejection. After extensive validation, they developed a sequencing-based targeted expression assay on the basis of this gene set that was able to identify subclinical rejection at 3 months post-transplant and increased risk of graft loss in an independent cohort of 110 patients. This assay represents a potentially useful tool to monitor kidney transplant recipients and optimize immunosuppressive therapy, although larger studies are needed to validate the assay\u2019s clinical utility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In kidney transplant recipients, surveillance biopsies can reveal, despite stable graft function, histologic features of acute rejection and borderline changes that are associated with undesirable graft outcomes. Noninvasive biomarkers of subclinical acute rejection are needed to avoid the risks and costs associated with repeated biopsies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We examined subclinical histologic and functional changes in kidney transplant recipients from the prospective Genomics of Chronic Allograft Rejection (GoCAR) study who underwent surveillance biopsies over 2 years, identifying those with subclinical or borderline acute cellular rejection (ACR) at 3 months (ACR-3) post-transplant. We performed RNA sequencing on whole blood collected from 88 individuals at the time of 3-month surveillance biopsy to identify transcripts associated with ACR-3, developed a novel sequencing-based targeted expression assay, and validated this gene signature in an independent cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Study participants with ACR-3 had significantly higher risk than those without ACR-3 of subsequent clinical acute rejection at 12 and 24 months, faster decline in graft function, and decreased graft survival in adjusted Cox analysis. We identified a 17-gene signature in peripheral blood that accurately diagnosed ACR-3, and validated it using microarray expression profiles of blood samples from 65 transplant recipients in the GoCAR cohort and three public microarray datasets. In an independent cohort of 110 transplant recipients, tests of the targeted expression assay on the basis of the 17-gene set showed that it identified individuals at higher risk of ongoing acute rejection and future graft loss.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our targeted expression assay enabled noninvasive diagnosis of subclinical acute rejection and inflammation in the graft and may represent a useful tool to risk-stratify kidney transplant recipients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1681\/asn.2018111098","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T18:55:19Z","timestamp":1562352919000},"page":"1481-1494","source":"Crossref","is-referenced-by-count":96,"title":["A Peripheral Blood Gene Expression Signature to Diagnose Subclinical Acute Rejection"],"prefix":"10.1681","volume":"30","author":[{"given":"Weijia","family":"Zhang","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengzi","family":"Yi","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Keung","sequence":"additional","affiliation":[{"name":"Department of Medicine, Westmead Clinical School, The University of Sydney, Sydney, New South Wales, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Shang","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Cornell Medical Center, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengguo","family":"Wei","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Cravedi","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeguo","family":"Sun","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Xi","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Woytovich","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Farouk","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqing","family":"Huang","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija","family":"Banu","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Gallon","sequence":"additional","affiliation":[{"name":"Department of Medicine-Nephrology, Northwestern University Feinberg School of Medicine, Chicago, Illinois;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciara N.","family":"Magee","sequence":"additional","affiliation":[{"name":"Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader","family":"Najafian","sequence":"additional","affiliation":[{"name":"Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milagros","family":"Samaniego","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Henry Ford Hospital, Detroit, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7675-6128","authenticated-orcid":false,"given":"Arjang","family":"Djamali","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin, Madison, Wisconsin;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen I.","family":"Alexander","sequence":"additional","affiliation":[{"name":"Department of Medicine, Westmead Clinical School, The University of Sydney, Sydney, New South Wales, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivy A.","family":"Rosales","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rex Neal","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Cornell Medical Center, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Lerut","sequence":"additional","affiliation":[{"name":"Pathology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Kuypers","sequence":"additional","affiliation":[{"name":"Nephrology and Renal Transplantation, University Hospitals Leuven, Leuven, Belgium; and"},{"name":"Department of Microbiology and Immunology, Katholieke Universiteit Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5625-0792","authenticated-orcid":false,"given":"Maarten","family":"Naesens","sequence":"additional","affiliation":[{"name":"Nephrology and Renal Transplantation, University Hospitals Leuven, Leuven, Belgium; and"},{"name":"Department of Microbiology and Immunology, Katholieke Universiteit Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"O\u2019Connell","sequence":"additional","affiliation":[{"name":"Department of Medicine, Westmead Clinical School, The University of Sydney, Sydney, New South Wales, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Colvin","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhav C.","family":"Menon","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Murphy","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,7,5]]},"reference":[{"issue":"Suppl 2","key":"B1-20231016","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/ajt.13666","article-title":"Kidney.","volume":"16","author":"Hart","year":"2016","journal-title":"Am J Transplant"},{"issue":"Suppl 1","key":"B2-20231016","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/ajt.14557","article-title":"OPTN\/SRTR 2016 annual data report: Kidney.","volume":"18","author":"Hart","year":"2018","journal-title":"Am J Transplant"},{"key":"B3-20231016","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM200003023420901","article-title":"Improved graft survival after renal transplantation in the United States, 1988 to 1996.","volume":"342","author":"Hariharan","year":"2000","journal-title":"N Engl J Med"},{"key":"B4-20231016","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1097\/00007890-199606150-00006","article-title":"Determinants of graft survival after renal transplantation.","volume":"61","author":"Pirsch","year":"1996","journal-title":"Transplantation"},{"key":"B5-20231016","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/01.ASN.0000056189.02819.32","article-title":"The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy.","volume":"14","author":"Shishido","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"B6-20231016","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/01.TP.0000128167.60172.CC","article-title":"Natural history, risk factors, and impact of subclinical rejection in kidney transplantation.","volume":"78","author":"Nankivell","year":"2004","journal-title":"Transplantation"},{"key":"B7-20231016","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1600-6143.2007.02049.x","article-title":"The utility of 1- and 3-month protocol biopsies on renal allograft function: A randomized controlled study.","volume":"8","author":"Kurtkoti","year":"2008","journal-title":"Am J Transplant"},{"key":"B8-20231016","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.transproceed.2011.03.078","article-title":"Treatment of subclinical injuries detected by protocol biopsy improves the long-term kidney allograft function: A single center prospective randomized clinical trial.","volume":"43","author":"Szederk\u00e9nyi","year":"2011","journal-title":"Transplant Proc"},{"key":"B9-20231016","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1111\/ajt.12370","article-title":"Kidney allograft survival after acute rejection, the value of follow-up biopsies.","volume":"13","author":"El Ters","year":"2013","journal-title":"Am J Transplant"},{"key":"B10-20231016","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/TP.0b013e31823bb647","article-title":"Early subclinical rejection as a risk factor for late chronic humoral rejection.","volume":"93","author":"Moreso","year":"2012","journal-title":"Transplantation"},{"key":"B11-20231016","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1111\/ajt.14627","article-title":"Short-term adverse effects of early subclinical allograft inflammation in kidney transplant recipients with a rapid steroid withdrawal protocol.","volume":"18","author":"Mehta","year":"2018","journal-title":"Am J Transplant"},{"key":"B12-20231016","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1111\/ajt.12426","article-title":"Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury.","volume":"13","author":"Hricik","year":"2013","journal-title":"Am J Transplant"},{"key":"B13-20231016","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1215555","article-title":"Urinary-cell mRNA profile and acute cellular rejection in kidney allografts.","volume":"369","author":"Suthanthiran","year":"2013","journal-title":"N Engl J Med"},{"key":"B14-20231016","doi-asserted-by":"crossref","first-page":"e1001759","DOI":"10.1371\/journal.pmed.1001759","article-title":"The kSORT assay to detect renal transplant patients at high risk for acute rejection: Results of the multicenter AART study.","volume":"11","author":"Roedder","year":"2014","journal-title":"PLoS Med"},{"key":"B15-20231016","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/ajt.15011","article-title":"Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplant.","volume":"19","author":"Friedewald","year":"2019","journal-title":"Am J Transplant"},{"key":"B16-20231016","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/ajt.15078","article-title":"The special relativity of non-invasive biomarkers for acute rejection.","volume":"19","author":"Naesens","year":"2019","journal-title":"Am J Transplant"},{"key":"B17-20231016","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1172\/JCI76902","article-title":"Intronic locus determines SHROOM3 expression and potentiates renal allograft fibrosis.","volume":"125","author":"Menon","year":"2015","journal-title":"J Clin Invest"},{"key":"B18-20231016","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(16)30826-1","article-title":"Biopsy transcriptome expression profiling to identify kidney transplants at risk of chronic injury: A multicentre, prospective study.","volume":"388","author":"O\u2019Connell","year":"2016","journal-title":"Lancet"},{"key":"B19-20231016","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: Inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"B20-20231016","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies.","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B21-20231016","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1111\/j.1600-6143.2012.04253.x","article-title":"A peripheral blood diagnostic test for acute rejection in renal transplantation.","volume":"12","author":"Li","year":"2012","journal-title":"Am J Transplant"},{"key":"B22-20231016","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/ajt.12671","article-title":"Molecular classifiers for acute kidney transplant rejection in peripheral blood by whole genome gene expression profiling.","volume":"14","author":"Kurian","year":"2014","journal-title":"Am J Transplant"},{"key":"B23-20231016","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1600-6143.2007.02137.x","article-title":"Peritubular capillaritis in renal allografts: Prevalence, scoring system, reproducibility and clinicopathological correlates.","volume":"8","author":"Gibson","year":"2008","journal-title":"Am J Transplant"},{"key":"B24-20231016","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/ni1008-1091","article-title":"The immunological genome project: Networks of gene expression in immune cells.","volume":"9","author":"Heng","year":"2008","journal-title":"Nat Immunol"},{"key":"B25-20231016","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/01.TP.0000082542.99416.11","article-title":"Protocol biopsy of the stable renal transplant: A multicenter study of methods and complication rates.","volume":"76","author":"Furness","year":"2003","journal-title":"Transplantation"},{"key":"B26-20231016","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/j.1600-6143.2004.00526.x","article-title":"Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes.","volume":"4","author":"Flechner","year":"2004","journal-title":"Am J Transplant"},{"key":"B27-20231016","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1111\/j.1600-6143.2012.04144.x","article-title":"Subclinical inflammation and chronic renal allograft injury in a randomized trial on steroid avoidance in pediatric kidney transplantation.","volume":"12","author":"Naesens","year":"2012","journal-title":"Am J Transplant"},{"key":"B28-20231016","doi-asserted-by":"crossref","first-page":"e82153","DOI":"10.1371\/journal.pone.0082153","article-title":"Identification of common blood gene signatures for the diagnosis of renal and cardiac acute allograft rejection.","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"B29-20231016","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1681\/ASN.2016091034","article-title":"Cell-free DNA and active rejection in kidney allografts.","volume":"28","author":"Bloom","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B30-20231016","doi-asserted-by":"crossref","first-page":"e0125045","DOI":"10.1371\/journal.pone.0125045","article-title":"Differentially expressed gene transcripts using RNA sequencing from the blood of immunosuppressed kidney allograft recipients.","volume":"10","author":"Dorr","year":"2015","journal-title":"PLoS One"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201908000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:29:33Z","timestamp":1786130973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201908000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,5]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2018111098","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,5]]}}}